By Jacob Gronholt-Pedersen COPENHAGEN, Nov 4 (Reuters) – Novo Nordisk's Wegovy pill beat third-quarter sales forecasts on Wednesday, a test of whether the Danish drugmaker's new oral weight-loss drug
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Following is a summary of current sports news briefs. Canada will bar Russians from competing…
By Michael Holden LONDON, Nov 3 (Reuters) - A cyberattack on supermarket fridges across Europe…
Nov 4 (Reuters) - Kazakhstan's services PMI was at 50.6 in October, down from 51.4…
VIDEO SHOWS: HIGHLIGHTS FROM PARIS MASTERS ATP 1000 TOURNAMENT INCLUDING - BEN SHELTON V CAMERON…
Combining regional storytelling, audience intelligence and technology to deliver objective-led brand solutions and sustainable creator…
By Jacob Gronholt-Pedersen and Patrick Wingrove COPENHAGEN, Nov 4 (Reuters) - Novo Nordisk's Wegovy weight-loss…